What to know about joint care near Mesa

Which route to check before you go

From west and central Mesa, Chandler is often the practical choice. Dobson Road runs south from Dobson Ranch without requiring a freeway.

From Downtown Mesa, you can take US-60 to Dobson Road. From Eastmark, Loop 202 Santan runs west toward the same area.

North of McDowell Road, Scottsdale may be closer. Loop 202 Red Mountain and Loop 101 lead toward Shea Boulevard.

Check traffic before leaving and allow time for a careful ride home. During a long trip, a stiff joint may need a stop.

Mesa doesn't have a QC Kinetix office. Your route will depend on which nearby office you call.

The travel choice is practical: compare driving time, help getting home, and follow-up visits. Those details matter before any procedure is scheduled.

Where to call when soreness won't settle

QC Kinetix uses orthobiologics as a broad name for PRP from blood, concentrated marrow, and similar joint procedures. The clinic's medical provider checks your joint and carries out treatment; ask if a doctor fills that role.

For PRP, the clinic spins a small amount of your blood to gather platelets. That prepared blood portion is put into the aching joint.

The Chandler location is at 1100 S. Dobson Road, Suite 210. You can call (602) 837-PAIN to ask for an appointment.

Tell the clinic which joint is sore and how long it has bothered you. Ask whether you'll need someone to drive after the procedure.

Bring earlier joint reports and your current medicine list. Ask whether the offered choice is PRP, concentrated PRP, or a named marrow procedure.

The closest office isn't always the right care. Decide after the procedure, travel, follow-up, and likely personal cost are clear.

Sources

1. The OARSI non-surgical management guideline evaluated 60 interventions with GRADE methodology and built its recommendations around core treatments - structured exercise, weight management and self-management education - for every patient with knee osteoarthritis, regardless of what else is added.

   Bannuru RR, et al. — OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage, 2019. DOI: 10.1016/j.joca.2019.06.011.

2. In a 480-patient, four-arm, multicenter randomized phase 2/3 trial, none of three orthobiologic cell injections - autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction, or allogeneic umbilical cord tissue-derived mesenchymal stromal cells - was superior to any other, or to a corticosteroid injection control, on pain at 12 months.

   Mautner K, et al. — Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial. Nat Med, 2023. DOI: 10.1038/s41591-023-02632-w.

3. FDA states in its consumer alert that the only FDA-approved stem cell products in the United States are blood-forming stem cells derived from umbilical cord blood, approved for disorders of the blood-forming system, and that NONE of these products - stem cells, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic fluid - has been approved for the treatment of any orthopedic condition, including osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain or shoulder pain.

   US Food and Drug Administration, Center for Biologics Evaluation and Research — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. , 2020.